Oral / gastric antibiotic decontamination reduced bacteremias in ICU - PulmCCM
Advertisement
May 072011
 

De Smet et al reheat the data from their 2009 NEJM study, in which they cluster-randomized and crossed-over 5,939 patients staying >48hrs in 13 Dutch ICUs to receive either 1) standard care; 2) selective oropharyngeal decontamination (topical amphotericin B, colistin, and tobramycin in the oropharynx), or 3) selective digestive tract decontamination (the same drugs in the mouth, stomach, and also IV cefotaxime for 4 days). Drugs were open-label, randomized by a blinded pharmacist. Back then, they reported a ~3% absolute mortality reduction in the treated groups.

Here, they report that patients in the standard-care group had more bacteremias (239 of 1837 or 13%), compared with 7-9% in the antibiotic-prophylaxed groups. Tracheal aspirates were obtained in ~50% of patients in all groups after ICU day 3. Cultures showed 15% of the patients in standard care had highly resistant bugs, compared to 8-10% in the prophylaxed groups. All values were statistically significant. Authors recommend these antibiotic regimens become standard care in ICUs. Lancet Infect Dis 2011;11:372-380.

They also report elsewhere that the IV+oral+stomach decontamination group had 1.4 gram-negative bacteremias per 1,000 days; the oral-only group, 3.0; and the standard-care group, 4.5. In their analysis, they argue against using the IV cefotaxime, saying it probably didn’t help. Crit Care Med 2011;39:961-966.

Liked this post? Get a weekly email update (no spam, ever), and explore our library of clinical guidelines, practice updatesreview articles. and board review questions.

PulmCCM is an independent publication, not affiliated with or endorsed by any other organization, society or journal referenced on the website.

Authors: contribute your work to PulmCCM Journal or in a guest blog post.

Leave a Comment